4-HYDROXY-6-OXO-1,6-DIHYDRO-1,3,5-TRIAZINE-2-CARBOXAMIDE
Modify Date: 2025-08-25 17:31:13
4-HYDROXY-6-OXO-1,6-DIHYDRO-1,3,5-TRIAZINE-2-CARBOXAMIDE structure
|
Common Name | 4-HYDROXY-6-OXO-1,6-DIHYDRO-1,3,5-TRIAZINE-2-CARBOXAMIDE | ||
|---|---|---|---|---|
| CAS Number | 69391-08-8 | Molecular Weight | 156.10000 | |
| Density | 2.19g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C4H4N4O3 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 4-HYDROXY-6-OXO-1,6-DIHYDRO-1,3,5-TRIAZINE-2-CARBOXAMIDEAllantoxanamide is a uricase inhibitor. Allantoxanamide-induced rats serve as animal models for studying purine biosynthesis, drug-induced hyperuricemia and hyperuricosuria, and related nephropathy[1]. |
| Name | 4,6-dioxo-1H-1,3,5-triazine-2-carboxamide |
|---|---|
| Synonym | More Synonyms |
| Description | Allantoxanamide is a uricase inhibitor. Allantoxanamide-induced rats serve as animal models for studying purine biosynthesis, drug-induced hyperuricemia and hyperuricosuria, and related nephropathy[1]. |
|---|---|
| Related Catalog | |
| Target |
Uricase[1]. |
| References |
| Density | 2.19g/cm3 |
|---|---|
| Molecular Formula | C4H4N4O3 |
| Molecular Weight | 156.10000 |
| Exact Mass | 156.02800 |
| PSA | 121.96000 |
| Index of Refraction | 1.861 |
| Oxonsaeureamid |
| 4,6-dioxo-1,4,5,6-tetrahydro-1,3,5-triazine-2-carboxamide |
| Allantoxanamide |
| Oxonamide |